IGFBP5 and idiopathic pulmonary fibrosis: For the pro-fibrotic factors, silencing IGFBP-5 reduced CTGF levels in IPF fibroblasts (Figure 4D), whereas silencing endogenous IGFBP-5 increased LOX expression (Figure 4E) at the examined time point of 48 h.